WCG Clinical Files to Withdraw IPO
WCG Clinical Files to Withdraw IPO
In August, the company said it planned to offer 45 million shares and expected the offering to price between $15 and $17 per share. By Stephen Nakrosis
作者：斯蒂芬·納克西
WCG Clinical, Inc. on Wednesday filed with the Securities and Exchange Commission to withdraw its initial public offering.
WCG Clinic，Inc.週三向美國證券交易委員會(Securities And Exchange Commission)提交了撤回其首次公開募股(IPO)的申請。
The company said it no longer wishes to conduct the offering at this time.
該公司表示，目前不再希望進行此次發行。
In August, the company said it planned to offer 45 million shares and expected the offering to price between $15 and $17 per share.
今年8月，該公司表示，計劃發行4500萬股票，預計發行價在每股15美元至17美元之間。
WCG Clinical said it provides clinical trial solutions and added it is "focused on providing solutions that are designed to measurably improve the quality and efficiency of clinical research, stimulate growth and foster compliance."
WCG Clinic表示，它提供臨牀試驗解決方案，並補充説，它“專注於提供旨在顯著提高臨牀研究質量和效率、刺激增長和促進遵從性的解決方案。”
The company said it had total revenue of $137.6 million for the three months ended March 31, 2021. In the three months ended March 31, 2020, the company said, it had total revenue of $103.4 million.
該公司表示，截至2021年3月31日的三個月總收入為1.376億美元。該公司表示，在截至2020年3月31日的三個月裏，總營收為1.034億美元。
Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
寫信給斯蒂芬·納克希爾斯，電子郵件：stehen.naksim@wsj.com
譯文內容由第三人軟體翻譯。
